Investing

Johnson & Johnson's (JNJ) Good Quarter

Johnson & Johnson (JNJ) announced third-quarter sales of $15.0 billion, an increase of 12.7% as compared to the third quarter of 2006.Net earnings and diluted earnings per share for the third quarter of 2007 were $2.5 billion and $.88, representing decreases of 7.7% and 6.4%, respectively, compared to the same period in 2006.

JNJ  increased its earnings guidance for full-year 2007, which excludes the impact of in- process research and development charges, restructuring charges or other special items, to between $4.10 and $4.13 per share
       

Douglas A. McIntyre
                                       

 

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.

AI Portfolio

Discover Our Top AI Stocks

Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.

You can follow him investing $500,000 of his own money on our top AI stocks for free.